Publications & Patents
HOMEPublications & Patents
Publications & Patents
LyseNTech Patents List
Lysentech / 2020-10-13
No. | Title | Application number | Authority | Application date | Status |
LNT001 | Bacteriophage of Pseudomonas aeruginosa and uses thereof | 10-1382893 | KR | 2014.04.01 | granted |
LNT002 | Bacteriophage of Salmonella enterica and uses thereof | 10-1449417 | KR | 2014.10.02 | granted |
LNT003 | Composition for infecting bacteria resistant to bacteriophage infection comprising bacteriophage PBECO4 or CEA derived therefrom and its use | 10-1607395 | KR | 2016.03.23 | granted |
LNT004 | Bacteriophage PA7 of Pseudomonas aeruginosa | 10-1612607 | KR | 2016.04.07 | granted |
LNT005 | Composition and method of increasing production of bacteriophage by use of Reactive oxygen species | 10-1909831 | KR | 2018.10.12 | granted |
LNT006 | Bacteriophage of Klebsiella pneumoniae and uses thereof | 10-2019-0022686 | KR | 2019.02.26 | applied |
LNT007 | Oncolytic T7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating cancer | 10-2209906 | KR | 2021.01.26 | granted |
LNT008 | Bacteriophage of Pseudomonas aeruginosa and uses thereof | 10-2019-0117450 | KR | 2019.09.24 | applied |
LNT009 | Oncolytic T7 bacteriophage having cytokine gene and displaying homing peptide on capsid and its use for treating cancer | US 16/685,516 | US | 2019.11.15 | applied |
LNT010 | Composition and method of increasing production of bacteriophage, using reactive oxygen species | US 16/642,599 | US | 2020.02.27 | applied |
LNT011 | Composition and method of increasing production of bacteriophage, using reactive oxygen species | EP 18851987.0 | EPO | 2020.03.17 | applied |
LNT012 | Novel Polypeptide and Antibiotics against Enterococcus spp. Bacteria Comprising the Polypeptide | 10-2224896 | KR | 2021.03.02 | granted |
LNT013 | Novel Polypeptide and Antibiotics against Gram-Negative Bacteria Comprising the Polypeptide | 10-2224897 | KR | 2021.03.02 | granted |
LNT014 | Polypeptide Variants and Antibiotics against Gram-Negative Bacteria Comprising the Same | 10-2228999 | KR | 2021.03.11 | granted |
LNT015 | Fusion Polypeptides and Antibiotics against Gram-Negative Bacteria Comprising the Same | 10-2286544 | KR | 2021.07.30 | granted |
LNT016 | Novel polypeptide, Fusion polypeptide, and Antibiotic against Gram-negative bacteria comprising the same | PCT/KR2021/006302 | PCT | 2021.05.20 | applied |
LNT017 | Novel Polypeptide and Antibiotics against Gram-Negative Bacteria Comprising the polypeptide | 10-2021-0199266 | KR | 2021.08.19 | applied |
LNT018 | Polypeptides, Fusion proteins, and Uses Thereof | 10-2022-0012566 | KR | 2022.01.27 | applied |